The 81st Annual Meeting of the Japanese Cancer AssociationThe 81st Annual Meeting of the Japanese Cancer Association

List of Session for which you can submit abstracts

Core Symposia

1 The new horizon of whole-genome sequencing in cancer
2 Cancer Immunology: Basic Research for Clinical Application
3 The latest development of precision oncology

International Sessions

1Novel immuno-epigenetic therapeutic approaches for tumor and microenvironment reprogramming
2Insight into Cancer Genome/Epigenome at the Single-cell Level
3Novel cancer therapy targeting for senescent cells
4Cancer immuno-genomic analysis to understand cancer immunology and predict immune therapy response
5New agent developments based on multi-omics analyses
6Recent advances in anti-tumor therapies targeting DNA metabolism
7From data science to mathematical modeling ~ new developments in mathematical oncology
8Liquid Biopsy: from discovery to clinical application
9Describing “cancer” from population-based data: Updated Approach
10Patient-derived models of cancer toward innovative precision medicine platform
11Aberrant RNA processing and cancer
12UICC

Symposia

1 Clonal evolution in normal and cancer tissues
2 Aging and cancer
3 Unraveling the relationship between diabetes, obesity, and cancer from clinical, epidemiological, and mechanistic perspectives
4 Plasticity and Diversity in Cancer
5 Genomic instability in cancers
6 Recent Advances in Cancer Epigenomics
7 Impacts of phase separation on cancer biology
8 Tumor microenvironment: Regulators of tumor invasion and metastasis
9 Metabolic alteration in the Tumor microenvironment
10 Bioresources and platforms that promote cancer research
11 Organoids: Cancer biology X-formation
12 Advanced animal models for unveiling cancer biology
13 Non-rodent animal model for personalized medicine
14 Clinical application of cancer research and its application to drug discovery based on AI science
15 Next-generation of cancer immunotherapy -Open the next era
16 Understanding cell signaling for therapeutic application
17 New trends in anti-cancer drug discovery
18 Current status and future perspective of oncolytic virus therapy and cellular immunotherapy
19 Dilemmas faced by epidemiologists - Considering the various gaps in the evidence
20 Cancer predisposing variants revealed by whole genome/exome sequencing.
21 Precision cancer prevention
22 Cutting Edge of carcinogenesis research
23 New horizons for cancer research driven by histopathological approaches
24 Emerging discoveries and developments for the next generation of precision medicine
25 New cancer research from engineering perspective